{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:26:42Z","timestamp":1791088002962,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.vaccine.2009.07.036","type":"journal-article","created":{"date-parts":[[2009,7,19]],"date-time":"2009-07-19T08:18:03Z","timestamp":1247991483000},"page":"5574-5580","source":"Crossref","is-referenced-by-count":80,"title":["Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages"],"prefix":"10.1016","volume":"27","author":[{"given":"Michael","family":"Br\u00f6ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Dull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.07.036_bib1","series-title":"Vaccines","first-page":"399","article-title":"Meningococcal vaccines","author":"Granoff","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2005-1314","article-title":"Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients","volume":"116","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.036_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1084\/jem.129.6.1385","article-title":"Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.036_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14712598.5.12.1611","article-title":"Towards an improved serogroup B Neisseria meningitidis vaccine","volume":"5","author":"Perrett","year":"2005","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.036_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.inf.0000259996.95965.ef","article-title":"Use of meningococcal vaccines in the United States","volume":"26","author":"Bilukha","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.279.6.435","article-title":"Efficacy of meningococcal vaccine and barriers to vaccination","volume":"279","author":"Rosenstein","year":"1998","journal-title":"JAMA"},{"issue":"8447","key":"10.1016\/j.vaccine.2009.07.036_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine","volume":"2","author":"Reingold","year":"1985","journal-title":"Lancet"},{"issue":"9580","key":"10.1016\/j.vaccine.2009.07.036_bib11","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.07.036_bib12","unstructured":"Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices. Recommended adult immunization schedule-United States, 2009. MMWR Morb Mortal Wkly Rep 2009;57(53)."},{"key":"10.1016\/j.vaccine.2009.07.036_bib13","unstructured":"Kingdom of Saudi Arabia Ministry of Health. Hajj health requirements 2008. http:\/\/www.moh.gov.sa\/en\/modules\/news\/article.php?storyid=394 [accessed January 12, 2009]."},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.285.2.177","article-title":"Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec","volume":"285","author":"De Wals","year":"2001","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.vaccine.2009.07.036_bib15","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1001\/jama.294.23.3019","article-title":"Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens","volume":"294","author":"Kelly","year":"2005","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.036_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/INF.0b013e3180cc2c25","article-title":"Reconsideration of the use of meningococcal polysaccharide vaccine","volume":"26","author":"Granoff","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"19","key":"10.1016\/j.vaccine.2009.07.036_bib17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib18","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants","volume":"56","author":"Gold","year":"1975","journal-title":"J Clin Invest"},{"issue":"9-10","key":"10.1016\/j.vaccine.2009.07.036_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0264-410X(00)00317-0","article-title":"Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults","volume":"19","author":"Borrow","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine","volume":"181","author":"Richmond","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","article-title":"Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults","volume":"11","author":"Southern","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.036_bib22","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age","volume":"73","author":"Al-Mazrou","year":"2005","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.036_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tmaid.2007.10.002","article-title":"Meningococcal disease: risk for international travellers and vaccine strategies","volume":"6","author":"Wilder-Smith","year":"2008","journal-title":"Travel Med Infect Dis"},{"issue":"31","key":"10.1016\/j.vaccine.2009.07.036_bib24","first-page":"794","article-title":"Revised recommendations of the advisory committee on immunization practices to vaccinate all persons aged 11\u201318 years with meningococcal conjugate vaccine","volume":"56","author":"Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.269.2.221","article-title":"Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era","volume":"269","author":"Adams","year":"1993","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.vaccine.2009.07.036_bib26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.036_bib27","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.036_bib28","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1046\/j.1440-1754.2001.00738.x","article-title":"Introduction of a conjugate meningococcal type C vaccine programme in the UK","volume":"37","author":"Salisbury","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.036_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.036_bib30","first-page":"61","article-title":"Progress introducing Haemophilus influenzae type b vaccine in low-income countries, 2004-2008","volume":"83","author":"World Health Organization (WHO)","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.036_bib31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/592691","article-title":"Pneumococcal vaccination of elderly adults: new paradigms for protection","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.036_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","article-title":"Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.036_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2147\/TCRM.S962","article-title":"Using the tetravalent meningococcal polysaccharide\u2013protein conjugate vaccine in the prevention of meningococcal disease","volume":"4","author":"Kimmel","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.036_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000126297.28952.f8","article-title":"Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants","volume":"23","author":"Rennels","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"10.1016\/j.vaccine.2009.07.036_bib35","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib36","first-page":"243","article-title":"Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study","volume":"25","author":"Halperin","year":"2002","journal-title":"Clin Invest Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.vaccine.2004.06.052","article-title":"Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines","volume":"23","author":"Huebner","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.036_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1442-200X.2003.01706.x","article-title":"Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine","volume":"45","author":"Kanra","year":"2003","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.036_bib39","first-page":"43","article-title":"Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines","volume":"94","author":"Matjila","year":"2004","journal-title":"S Afr Med J"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.036_bib40","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2009.07.036_bib41","series-title":"Vaccine adjuvants: immunological and clinical principles","article-title":"Modified bacterial toxins","author":"Lavelle","year":"2006"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.036_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/AEM.46.3.560-564.1983","article-title":"Isolation and characterization of Corynebacterium diphtheriae nontandem double lysogens hyperproducing CRM197","volume":"46","author":"Rappuoli","year":"1983","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.036_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.143.4.1259","article-title":"Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling","volume":"143","author":"Sepp\u00e4l\u00e4","year":"1989","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.036_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI115564","article-title":"Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates","volume":"89","author":"Paoletti","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.036_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.036_bib46","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1128\/IAI.65.12.4918-4925.1997","article-title":"A strategy for rational design of fully synthetic glycopeptide conjugate vaccines","volume":"65","author":"Chong","year":"1997","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.07.036_bib47","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","article-title":"Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1","volume":"96","author":"Pozsgay","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.036_bib48","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/IAI.69.7.4698-4701.2001","article-title":"Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice","volume":"69","author":"Benaissa-Trouw","year":"2001","journal-title":"Infect Immun"},{"issue":"9-10","key":"10.1016\/j.vaccine.2009.07.036_bib49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0264-410X(98)00348-X","article-title":"Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines","volume":"17","author":"Costantino","year":"1999","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.07.036_bib50","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2004.10.021","article-title":"Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135","volume":"23","author":"Bardotti","year":"2005","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2009.07.036_bib51","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","article-title":"Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases","volume":"26","author":"Bardotti","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.036_bib52","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.142.7.2464","volume":"142","author":"Anderson","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.07.036_bib53","series-title":"45th Annual Meeting of the Infectious Diseases Society of America","article-title":"Safety and immunogenicity 12 months post-vaccination with novartis vaccines\u2019 tetravalent glycoconjugate meningococcal ACWY vaccine in children aged 2\u201310 years","author":"Black","year":"2007"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/INF.0b013e31818a0237","article-title":"A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents","volume":"28","author":"Jackson","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.07.036_bib56","series-title":"44th Annual Meeting of the Infectious Diseases Society of America","article-title":"Safety, immunogenicity and immune memory of a non-adjuvanted meningococcal (serogroups A, C, W-135 and Y) glycoconjugate vaccine in healthy infants","author":"Perrett","year":"2006"},{"key":"10.1016\/j.vaccine.2009.07.036_bib57","unstructured":"Jackson L, Baxter R, Reisinger KS, Shah J, Bedell L, Dull PM. A Phase III study comparing the safety and immunogenicity of a novel quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, with the licensed MCV4, Menactra\u2122, in adolescents. Pediatric Academic Societies Annual Meeting 2008."},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.036_bib58","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.260.10.1423","article-title":"Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota","volume":"260","author":"Osterholm","year":"1988","journal-title":"JAMA"},{"issue":"4 Pt 2","key":"10.1016\/j.vaccine.2009.07.036_bib59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1542\/peds.85.4.643","article-title":"Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine","volume":"85","author":"Shapiro","year":"1990","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.vaccine.2009.07.036_bib60","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.036_bib61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/155.1.100","article-title":"Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid","volume":"155","author":"K\u00e4yhty","year":"1987","journal-title":"J Infect Dis"},{"issue":"2 Pt 1","key":"10.1016\/j.vaccine.2009.07.036_bib62","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","article-title":"Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines","volume":"120","author":"Decker","year":"1992","journal-title":"J Pediatr"},{"issue":"20","key":"10.1016\/j.vaccine.2009.07.036_bib63","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199011153232006","article-title":"Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group","volume":"323","author":"Ward","year":"1990","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.036_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00006454-199306000-00006","article-title":"Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants","volume":"12","author":"Bulkow","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.036_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","article-title":"Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group","volume":"10","author":"Black","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"10.1016\/j.vaccine.2009.07.036_bib66","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T01:57:26Z","timestamp":1685066246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":66,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0264410X09010457"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}